EP1715890
CTGF AS TARGET FOR THE THERAPY OF MICROALBUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.2.2005:
9.7.2008:
05713358.9
:
10.2.2025
:
CTGF AS TARGET FOR THE THERAPY OF MICROALBUMINURIA IN PATIENTS WITH DIABETIC NEPHROPATHY
11.2.2005
9.7.2008
:
FIBROGEN, INC.:
225 Gateway Boulevard, South San Francisco, CA 94080, US
:
FLYVBJERG, Allan:
Odder, DK
:
GUO, Guangjie:
Foster City, CA 94404, US
:
LIU, David, Y.:
Palo Alto, CA 94306, US
:
NEFF, Thomas, B.:
Atherton, CA 94027, US
:
OLIVER, Noelynn, A.:
Los Altos, CA 94022, US
:
USINGER, William, R.:
Lafayette, CA 94549, US
:
WANG, Qingjian:
Belmont, CA 94002, US
:
544121 P:
11.2.2004:
US
:
561018 P:
8.4.2004:
US
:
578401 P:
9.6.2004:
US
:
620802 P:
20.10.2004:
US
:
WO2005077413:
11.2.2005